Resources
- State CME Requirements
- CME Policies
- Contact Medscape about CME/CE questions.
Diabetes & Endocrinology CME
- Advances in Glucagon-like Peptides for the Treatment of Type 2 Diabetes
- The Unraveling of Incretin Biology: New Dimensions in the Management of Type 2 Diabetes
- Cardiometabolic Risk Reduction in Patients With Type 2 Diabetes: Evolving Science and Emerging Strategies
- Multihormonal Treatment Approaches and the Diabetes-Obesity Continuum
- The Altered Adrenal Axis and Treatment With Glucocorticoids During Critical Illness
- Ready for Primetime: Incretin-Based Therapies Play a Novel Role in the Treatment of Type 2 Diabetes
- Managing Type 2 Diabetes: Developing Office-based Systems of Care
- Diabetes News Desk: Hot Topics, Current Issues
- ADA 2008: Incretin-Based Therapeutics
- ADA 2008: Clinical Questions
- ADA 2008: Emerging Treatments for Hyperglycemia
- Targeting the Interplay of Obesity, Insulin Resistance and Mixed Dyslipidemia: An Integrative Approach to Reducing Cardiometabolic Risk
- The Pathogenesis of Diabetic Nephropathy
- Dawning of a New Age in Type 2 Diabetes Care: An Expanding Role for Injectable Agents
- Cardiometabolic Risk and Atrial Fibrillation in a 48-year-old Man: Case Study
- Achieving Targets in Type 2 Diabetes: Interactive Patient Cases
- Chronic Management of Obesity: A Comprehensive Approach to Reducing CV Risk
- The Role of Thyroid Autoimmunity in Fertility and Pregnancy
- Long-term Effects of Pegvisomant in Patients With Acromegaly
- The Comorbid Relationship of Hypogonadism and Type 2 Diabetes Mellitus in the Aging Male
- Emerging Strategies for the Clinical Management of Chronic Obesity
- Sodium-Glucose Transporter 2 Inhibitors: New Therapeutic Targets, New Therapeutic Options in the Treatment of Type 2 Diabetes Mellitus
- The Role of Incretin-Based Therapies: Reconstructing Treatment Approaches in Type 2 Diabetes
- Drug Insight: Insulin-Sensitizing Drugs in the Treatment of Polycystic Ovary Syndrome – A Reappraisal
- Type 2 Diabetes--Restoring Glucose Homeostasis with Incretin Therapy: New Perspectives on Old Challenges
- From Inpatient to Outpatient: Practical Strategies for Optimizing Treatment of Hyperglycemia and Type 2 Diabetes Mellitus
- Clinical Implications of a Molecular Genetic Classification of Monogenic Beta-cell Diabetes
- Weight Loss and Metabolic Benefits With Diets of Varying Fat and Carbohydrate Content: Separating the Wheat From the Chaff
- Therapy Insight: Metabolic and Endocrine Disorders in Sickle-cell Disease
- Renal Disease and Anemia: Interrelationships and Clinical Implications
- Managing Obesity as a Chronic Disease: A Pathophysiologic Approach to Cardiometabolic Risk Reduction
- The Diabetes-Obesity Continuum: The Growing Body of Evidence for a Multi-hormonal Approach to Treatment
- Designing an Architecture for Change: Constructing Optimum Treatment Regimens for Type 2 Diabetes
- New Therapeutic Approaches to Treat Medullary Thyroid Carcinoma
- Type 2 Diabetes and Cardiovascular Risk: Integrating Physician and Educator Perspectives
- CSI: Investigating Incretin Therapies From Potential to Practice
- Management Approaches for Pediatric Obesity
- Emerging Data to Guide Clinical Decisions: Abdominal Adiposity and Cardiometabolic Risk
- Cases in the Management of Type 2 Diabetes: Targets and Treatments
- Genetics of Adrenal Tumors Associated With Cushing's Syndrome: A New Classification for Bilateral Adrenocortical Hyperplasias
- Incretin Therapeutics: A New Option in the Management of Type 2 Diabetes
- In-Hospital Management of Patients With Hyperglycemia: Transitioning From IV Insulin Therapy to Subcutaneous Insulin Regimens and Effective Discharge Planning to Maintain Glycemic Control (An Interactive Case Study)
- The Reproductive Phenotype in Polycystic Ovary Syndrome
- Emerging Developments With Incretin-Based Therapeutics: Will They Impact the Management of Diabetes?
- Growth Hormone Treatment in Children: Case Studies in Turner and Prader-Willi Syndromes
- Interactive Discussion With the Experts on Incretins: Preserving Pancreatic Function in Diabetes
Related CME
- Management of Elevated Cholesterol in a Patient With Previous MI
- Revealing the Complexities and Uncertainties of the Cardiometabolic Syndrome: A Focus on Hypertensive Disease
- Small for Gestational Age: Issues in 2008
- Diabetes Screening, Diagnosis, and Therapy in Pediatric Patients With Type 2 Diabetes
- Which Drugs, When, for the Hypertensive Patient With Risk Factors?
- New Strategies and Therapeutic Advances in Renal Transplantation
- Barrett Esophagus: Prevalence of Central Adiposity, Metabolic Syndrome, and a Proinflammatory State
- New Approaches to Managing Dyslipidemia: Risk Reduction Beyond LDL-C
- Dietary Fructose Consumption Among US Children and Adults: The Third National Health and Nutrition Examination Survey
- Cases in CAM: What's the Good of Flaxseed?
- New Targets in Global Cardiovascular Risk Reduction: Considering the Whole Patient
- Men's Sexual Health Consult Collection: Testosterone Replacement Therapy in the VA Setting
- Outpatient Parenteral Antimicrobial Therapy For A Diabetic Patient With A Foot Infection
- Diagnosis and Management of Hypertension and Cardiovascular Risk Factors in African-American Patients
- The Changing Shape of Type 2 Diabetes
- Cases from AHRQ WebM&M: The Wrongful Resuscitation
- Cardiovascular Risk Management in Diabetes: A Cross-Specialty Approach to the Clinical Challenges
- ACC 2008: The Future of Managing Dyslipidemia
- Critical Updates: The Role of Atherosclerosis, Hypertension and Diabetes in Cardiovascular Disease: Call to Action for the Cardiologist
- The Skinny on Weight Loss Supplements: Fact or Fantasy?
- Cultural Competency in Healthcare: A Clinical Review and Video Vignettes From the National Medical Association
- Educating the Health Professional for Improving Cultural Competency
- Individualizing Antiretroviral Therapy on the Basis of Comorbidities and the Risk for Viral Resistance
- Controversies in Late-Onset Hypogonadism: A Panel Discussion
- Drug Mix-Ups Threaten Patient Safety
- Spotlight on HDL-raising Therapies: Insights From the Torcetrapib Trials
- Management of Cardiovascular Risk Factors: Evidence-based Practice and Approaches
- In Light of Recent Controversies in Treating Dyslipidemia, Is Lowering LDL Still the Target?
- Differentiating Leg Disorders: Strategies for Diagnosis and Treatment in the Primary Care Setting
- Beta-Blockers in Hypertension: Should We Discard Them?
- Hirsutism
- Drug Insight: Choosing a Drug Treatment Strategy for Women With Osteoporosis--An Evidence-Based Clinical Perspective
- Cases from AHRQ WebM&M: Contaminated or Not? Guidelines for Interpretation of Positive Blood Cultures
- Emerging Data in the Treatment of Mixed Dyslipidemia
- Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients: 144-Week Analysis
- Aging and the HIV Patient: A Video Lecture With William Powderly, MD
- Mechanisms and Syndromes of Cardiometabolic Disease: Emerging Science in Atherosclerosis, Hypertension and Diabetes
- CROI 2008: Challenges in Antiretroviral Therapy: Complications, Pharmacology, and Resistance Issues
- Prevention of Antibiotic Resistance in the ICU: Application of the CDC 12-Step Program to Prevent Antimicrobial Resistance in Healthcare Settings
- CROI 2008: Emerging Strategies in Antiretroviral Therapy: Clinical Trials in Naïve and Experienced Patients
- Predictive Factors of Outcome After Gastric Banding: A Nationwide Survey on the Role of Center Activity and Patients' Behavior
- Neurohormonal Regulators of Obesity: Mediating Weight Loss Through Peptide Hormone Therapeutics
- Turning Adverse Drug Events Into Better Patient Care
- Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension: AHRQ Executive Summary
- An Overweight Smoker With Mixed Dyslipidemia: When Lifestyle Modification and Statins Aren't Enough
- A Randomized, Multicenter, Open-Label Study of Poly-L-Lactic Acid for HIV-1 Facial Lipoatrophy
- Management of Hypertension in Black Patients in the Primary Care Setting: Focus on Calcium Channel Blockers
- Recognizing and Treating Androgen Deficiency Syndrome in Aging Men
- Early Identification and Treatment of Mineral and Bone Disorders in CKD Stages 3 and 4
- Testosterone and Mortality: An Expert Interview With Dr. Adrian S. Dobs
- Cardiometabolic Risk in the Spotlight: Which Therapies Should Take Center Stage?
- Assuring Quality Care for People With Limited Health Literacy
- New Agents In Development For the Management of Obesity
- The Next Frontier in CV Risk Reduction: Increasing HDL-C in Patients with Mixed Dyslipidemia
- Top Herbal Products: Efficacy and Safety Concerns
- Do Patients With Diabetes Wear Shoes of the Correct Size?
- Late-Onset Male Hypogonadism: A Clinical Update
- Highlights of the American Heart Association (AHA) 2007 Scientific Sessions
- Nonpharmacologic Management of Osteoporosis to Minimize Fracture Risk
- Endocrine Emergencies
- Association of Upper Trunk and Visceral Adipose Tissue Volume With Insulin Resistance in Control and HIV-Infected Subjects in the FRAM Study
- Challenges in Managing the Complications of Renal Transplantation: A Case Study Review
- Assessing Health Literacy in Clinical Practice
- Highlights of the XVI International Symposium on Drugs Affecting Lipid Metabolism
- ASN 2007: Emerging Therapies for Management of Mineral Bone Disorders in Chronic Kidney Disease
- HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population
- Small Steps and Practical Approaches to the Treatment of Obesity
- Validation of the Obesity Surgery Mortality Risk Score in a Multicenter Study Proves It Stratifies Mortality Risk in Patients Undergoing Gastric Bypass for Morbid Obesity
- Quality of Life and Metabolic Status in Mildly Depressed Patients With Type 2 Diabetes Treated With Paroxetine: A Double-Blind Randomised Placebo Controlled 6-Month Trial
- Challenges of Treating Tobacco Users in High-Risk Populations
- ICAAC: HIV-Related Opportunistic Diseases
- Topical Treatments for Fat Reduction -- Do They Work? A Best Evidence Review
- Minimizing the Risk for Glucose Intolerance and Cardiovascular Disease in Patients With HIV
- Skin Biopsy as a Diagnostic Tool in Peripheral Neuropathy
- Metabolic Disturbances Associated With the Use of Second-Generation Antipsychotics
- "Opt-out" HIV Testing and First-line Therapy
- Assessment of the Neck and Lymph Nodes in the Elderly Patient
- Stress and Obesity: Partners in Disease
- Quality Improvement in Healthcare
- Which Health-Related Quality of Life Score? A Comparison of Alternative Utility Measures in Patients With Type 2 Diabetes in the ADVANCE Trial
- An Update on Adult Immunizations for Vaccine-Preventable Diseases
- What Is Anaphylaxis?
- Improving Risk Prediction Precision and Care: From "Intermediate Risk" to Office-based Therapeutic Interventions
- Epidemiology and Treatment of HIV in African Americans
News CME
CME Advisory Board
- John G. Bartlett, MD, MACP
- Marcia J. Jackson, PhD, FACME (Chair)
- John R. Kamp, PhD, JD
- George D. Lundberg, MD, FCAP, FASCP
- Cecilia F. Mulvey, PhD, RN
- Judith Ribble, PhD, FACME
- William M. Silberg
Director
Accreditation Coordinator
Coordinators